REGENPEP

Live / Allowed — Third extension granted (statement of use) (as of 24 Aug 2026)

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 24 May 2024 filing date already counts against anyone who files later.

Record

Serial number
98567742
Mark type
Word mark
Filed
24 May 2024
Published for opposition
07 Jan 2025
Attorney of record
Michael J. Hertz

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceuticals, namely, preparations for the treatment of diabetes, autoimmune thyroiditis, polyneuropathy, autoimmune biliary diseases and poly autoimmunity, degenerative diseases, and other diseases requiring both cellular regenerative activity and suppression of autoimmunity

Owner

Prosecution history

  • 25 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 24 Aug 2026 — SOU EXTENSION 3 GRANTED
  • 24 Aug 2026 — SOU EXTENSION 3 FILED
  • 24 Aug 2026 — SOU TEAS EXTENSION RECEIVED
  • 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 03 Mar 2026 — SOU EXTENSION 2 GRANTED
  • 03 Mar 2026 — SOU EXTENSION 2 FILED
  • 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
  • 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 29 Aug 2025 — SOU EXTENSION 1 GRANTED
  • 29 Aug 2025 — SOU EXTENSION 1 FILED
  • 29 Aug 2025 — SOU TEAS EXTENSION RECEIVED
  • 04 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 07 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 07 Jan 2025 — PUBLISHED FOR OPPOSITION

View this trademark record on Rightsy